Disruption of cell-matrix interactions can lead to anoikis -apoptosis due to loss of matrix contacts. Altered fibronectin (FN) induces anoikis of primary human fibroblasts by a novel signaling pathway characterized by reduced phosphorylation of focal adhesion kinase (FAK). However, the receptors involved are unknown. FAK phosphorylation is regulated by nerve/glial antigen 2 (NG2) receptor signaling through PKCa a point at which signals from integrins and proteoglycans may converge. We found that an altered FN matrix induced anoikis in fibroblasts by upregulating NG2 and downregulating integrin a4. Suppressing NG2 expression or overexpressing a4 rescued cells from anoikis. NG2 overexpression alone induced apoptosis and, by reducing FAK phosphorylation, increased anoikis induced by an altered matrix. NG2 overexpression or an altered matrix also suppressed PKCa expression, but overexpressing integrin a4 enhanced FAK phosphorylation independently of PKCa. Cotransfection with NG2 cDNA and integrin a4 siRNA did not lower PKCa and pFAK levels more than transfection with either alone. PKCa was upstream of FAK phosphorylation, as silencing PKCa decreased FAK phosphorylation. PKCa overexpression reversed this behavior and rescued cells from anoikis. Thus, NG2 is a novel proapoptotic receptor, and NG2 and integrin a4 oppositely regulate anoikis in fibroblasts. NG2 and integrin a4 regulate FAK phosphorylation by PKCa-dependent and -independent pathways, respectively. Cell Death and Differentiation (2008) The extracellular matrix (ECM) glycoprotein fibronectin (FN) affects adhesion, migration, survival, and other cellular functions. FN fragments found in vivo and associated with disease or comparable recombinant fragments trigger apoptosis/anoikis in primary human fibroblasts via a novel pathway regulated by decreases in focal adhesion kinase (FAK) phosphorylation and downregulation of p53.
1
Integrins are a and b heterodimeric cell-surface receptors that mediate cell-ECM interactions and regulate cell adhesion, migration, proliferation, and survival. Interactions between FN and integrins promote the survival of many cell types. We showed that blocking antibodies against the a4 integrin subunit induced apoptosis-like cell rounding in human fibroblasts, similar to that induced by anoikis in response to an altered FN matrix fragment. 2 Integrins mediate those responses by binding ECM ligands and activating signaling cascades that promote these actions. The a4 integrin subunit can bind to at least three interaction sites on FN. These include the arginine-glycine-aspartic acid site on the central cell-binding domain, the V region, and the heparin-binding domain. Once engaged, integrins alter cell behavior by recruiting and activating signaling proteins, including FAK. Integrin-FAK signaling complexes may help regulate anchorage-dependent cell survival. 4 FAK is critical in protecting cells from apoptosis, but the mechanisms are not fully characterized. 4, 5 Constitutive activation of FAK protects epithelial cells from anoikis, 4 while interference with FAK function in fibroblasts and endothelial cells triggers apoptosis by a p53-dependent mechanism. 5, 6 PKC also plays a role in integrin-mediated cell adhesion, spreading, 7, 8 migration, 7 FAK phosphorylation, 9 and focal adhesion formation. 10 PKC appears to be a key intermediate between integrins and FAK signaling in many cell types. 11 PKC activation is required for FAK phosphorylation in cells plated on FN. 7, 9 FN also interacts with proteoglycans. Proteoglycans have been implicated in the regulation of apoptotic pathways, but little is known about the mechanism. The chondroitin sulfate proteoglycan (CSPG) nerve/glial antigen 2 (NG2) and the a4b1 integrin have been proposed as coreceptors with distinct signaling roles in mediating the spread of melanoma cells on FN-coated surfaces. 12, 13 Thus, NG2 might work in concert with a4b1 to regulate anoikis induced by an altered FN matrix.
NG2 is expressed on the surface of various cell types and its expression decreases with terminal differentiation. 14, 15 NG2 is a transmembrane receptor that interacts with ECM molecules, such as type VI collagen, and with other cellsurface components, including b1 integrins, to mediate cell adhesion and proliferation. 16, 17 The cytoplasmic domain of NG2 interacts with scaffolding proteins such as MUPP1 18 and GRIP1 19 and with kinases such as PKCa and ERK. 17 NG2 also regulates FAK and ERK activation by distinct mechanisms in human melanoma cells. 13 However, regulation of FAK phosphorylation through proteoglycans in apoptosis has not been studied, and the role of NG2 in regulating apoptosis by the ECM is unknown.
We tested the hypothesis that NG2 acts in concert with a4b1 to regulate anoikis induced by an altered FN matrix (V þ HÀ) in human fibroblasts. We also tested the possibility that PKCa and FAK signaling are control points where these two receptor-mediated signaling pathways converge to regulate this process.
Results
A CSPG is involved in anoikis triggered by an altered FN matrix. As previously shown, [1] [2] [3] an altered FN matrix consisting of the V þ HÀ protein induced apoptosis in primary ligament fibroblasts (Figure 1a and b). Cells treated with an altered FN matrix exhibited nuclear condensation and bright DAPI staining typical of apoptotic cells. Cells treated with an altered FN matrix also had significantly higher levels of apoptosis, as assessed by flow cytometry, than cells treated with serum-free medium or the control V þ H þ FN protein.
To identify the receptors mediating this apoptotic mechanism, we first determined if proteoglycans might be involved, as FN binds to proteoglycans and integrins. Specifically, since the heparin-binding domain of FN interacts with CSPGs and heparin sulfate proteoglycans, we investigated this possibility under anoikis conditions by altering surface GAGs, using the traditional method of removing CS and/or HS with specific enzymes.
1 Pretreatment with chondroitinase ABC rescued cells from apoptosis induced by the altered FN matrix (Figure 1c ), but pretreatment with heparinase III did not (Figure 1d ). Cell rescue after pretreatment with both glycosaminoglycans was similar to that in cells treated with chondroitinase ABC alone (Figure 1e ).
NG2 proteoglycan expression is regulated by anoikis. To determine if a CSPG receptor mediates anoikis triggered by an altered FN matrix, we measured the expression of several CSPGs. In cells treated with an altered FN matrix, NG2 levels increased at 2 h and decreased at 4 h (Figure 2a NG2 is a proapoptotic receptor. Next, we determined if up-or downregulation of NG2 is critical for anoikis induced by an altered FN matrix. Transient transfection with NG2 siRNA (100 pmol) rescued cells from apoptosis, as shown by morphology, a quantitative flow cytometric apoptosis assay, and a cell death ELISA assay that measures DNA fragmentation; however, transfection with NG2 cDNA (1 mg) increased apoptosis, indicating that NG2 is a proapoptotic receptor (Figure 3a -e). The B5 antibody used for immunoblotting recognizes both endogenous human NG2 and transfected rat NG2, so the immunoblotting results represent the total amount of NG2 in the cells. These data also demonstrate that anoikis induced by the altered FN matrix is mediated by the increase in NG2 expression at 2 h, not the decrease at 4 h (Figure 2a , c-e). To further confirm that NG2 is a proapoptotic receptor, NG2-null (NG2À/À) cells were compared to NG2-positive (NG2 þ / þ ) cells under anoikis conditions. Like primary cells overexpressing NG2 siRNA, NG2-null cells were resistant to apoptosis (Figure 3f-h ).
Anoikis conditions decrease integrin a4 expression. Since integrin a4 and the NG2 work cooperatively to mediate the spreading of melanoma cells on FN, 12, 13 we tested whether integrin a4 cooperates with NG2 to regulate anoikis in cells treated with an altered FN matrix. At 2 and 4 h after treatment, integrin a4 protein levels were decreased (Figure 4a ), but integrin a5 and av levels were not affected ( Figure 4b ). These findings were confirmed by flow cytometric and immunofluorescence analyses (Figure 4c Integrin a4 is an anti-anoikis regulator. To further examine the role of integrin a4 in anoikis in primary fibroblasts, we overexpressed integrin a4 using cDNA and suppressed a4 expression with siRNA. Cells overexpressing integrin a4 and treated with altered FN matrix were well spread and were morphologically similar to transfection controls and cells treated with the control FN protein ( Figure 5a ). As shown by a quantitative flow cytometric assay and cell death ELISA assay, overexpression of integrin a4 rescued cells from apoptosis ( Figure 5b and d). Cells transfected with a4 siRNA were also morphologically similar to controls (Figure 5a ). However, when they were treated with an altered FN matrix, apoptosis was more pronounced than in untransfected cells treated with altered FN matrix ( Figure 5c and e), suggesting a synergistic effect of a4 siRNA. Interestingly, suppression of integrin a4 expression alone did not significantly affect apoptosis levels, compared to control transfected cells. Since basal levels of a4 are generally low in these cells (Figure 5b ), western blots to detect a4 suppression by siRNA ( Figure 5c ) were developed for a longer time.
FAK phosphorylation by NG2, but not by integrin a4, is PKCa dependent. To study the signaling mechanisms and potential cross-talk by which NG2 and integrin a4 regulate anoikis, we measured PKCa expression and phosphorylation of FAK, which are early signaling events in both receptor pathways. Total FAK levels were similar under different conditions, but phosphorylation of FAK at Tyr-397 and PKCa expression were decreased in cells treated with an altered FN matrix, as shown by western blot (Figure 6a ). To further determine how PKCa signals are regulated and the extent to which NG2 and integrin a4 contribute to the regulation, we transfected cells with integrin a4 and NG2 cDNAs or a4 siRNA. Phosphorylation of FAK at Try-397 was increased by overexpression of integrin a4 (Figure 6b ) and decreased by suppression of a4 (Figure 6c ), but PKCa expression and total FAK protein levels were unaffected. In contrast, overexpression of NG2 decreased both PKCa and pFAK expression (Figure 6c ). Cotransfection of NG2 cDNA and integrin a4 siRNA did not alter PKCa or pFAK levels more than NG2 cDNA transfection alone. Thus, NG2 negatively regulates PKCa and pFAK levels, whereas integrin a4 positively regulates only pFAK levels. Finally, to determine if PKCa is upstream of pFAK in anoikis signaling, we assessed the effects of PKCa siRNA and cDNA. FAK phosphorylation was decreased by silencing PKCa and increased by overexpressing PKCa (Figure 7a and b) . These findings were confirmed by western blot. Total FAK protein levels were unchanged. PKCa overexpression rescued cells from apoptosis/anoikis (Figure 7c ). 
Discussion
Previously, we showed that an altered FN matrix triggers apoptosis or anoikis in primary human fibroblasts via a signaling pathway that is regulated by decreases in FAK phosphorylation and p53 expression. 1 However, the receptors involved were not known. Initial studies (Figure 1 ) with chondroitinase treatment suggested, since removal of CS GAGs but not HS GAGs rescued cells from anoikis, that the receptor mediating this mechanism might contain CS moieties, and thus might be a CSPG receptor. In this study, we showed that the proteoglycan NG2 and integrin a4 oppositely regulate this process. Treatment with an altered FN matrix induced anoikis in cells overexpressing NG2 but not in those overexpressing integrin a4. NG2 overexpression on its own induced apoptosis, whereas suppression of NG2 rescued cells from anoikis. These findings show that NG2 is a proapoptotic receptor.
NG2 regulates cell proliferation, migration, spreading, and adhesion in melanomas, gliomas, oligodendrocyte progenitors, and pericytes 16, 17, 20, 21 and increases metastasis of melanoma cells. 20 It has never been implicated in apoptosis. Other proteoglycans, including syndecan-2 and syndecan-4, decorin, biglycan, CD44, and heparan sulfate proteoglycans promote or block apoptosis by modulating growth factor or integrin receptor function or by altering cell aggregation or specific signaling networks. [22] [23] [24] [25] NG2 also modulates growth factor receptor and integrin function to regulate a variety of cellular processes. 17, 26 In addition, NG2 and integrin a4 act as coreceptors in focal contact formation and spreading of melanoma.
12, 13 Here, we found that NG2 and integrin a4 work in opposition to modulate anoikis and that the proapoptotic activity of NG2 is increased under conditions of anoikis.
How can NG2 and a4b1 work in concert to mediate adhesion to intact FN but work in opposition to regulate apoptosis in response to FN fragments? Compared to intact FN, FN fragments lack many of its binding sites and its threedimensional conformation, thus limiting the cellular responses the fragments can mediate. Also, NG2 decreases the adhesion of melanoma cells to CD44 monoclonal antibodies, hyaluronic acid, the C-terminal 40-kDa FN fragment, and the CS1 FN peptide, suggesting that NG2 may inhibit CD44-and a4-mediated events. 20 Consistent with this notion, we found that NG2 overexpression promotes apoptosis by opposing integrin a4-mediated survival signals transmitted by pFAK. Along similar lines, NG2 and a4 may function as competitive inhibitors. For example, a4 and NG2 might bind to the same LDV hot spots on the FN fragment. 27 Thus, if a4 is blocked, NG2-mediated adhesion increases; conversely, if NG2 is blocked, a4-mediated adhesion increases.
Integrin-mediated survival pathways involve the phosphorylation and activation of intracellular tyrosine kinases, such as FAK. 28, 29 FAK itself may be modulated by PKC signaling, as in focal adhesion formation and in regulating downstream signals from FAK, which are important for cell survival, cell spreading, and cell migration. 30 NG2 interacts directly with both PKCa and ERK 17 and appears to regulate FAK and ERK activation; 13, 26, 31 however, it was not known whether NG2-mediated signal transduction pathways lead to apoptosis or anoikis. We found anoikis signals mediated by an altered FN matrix and transmitted by NG2 led to decreases in PKCa and pFAK levels. Overexpression of integrin a4 increased pFAK (Tyr-397), but not PKCa levels, indicating that the pFAK survival signal is mediated independently of PKCa. Overexpression of NG2 decreased both PKCa levels and phosphorylation of FAK, while suppression of PKCa decreased FAK phosphorylation, indicating that NG2 regulates FAK phosphorylation through PKCa in fibroblasts. Thus, NG2, but not integrin a4, regulates anoikis of fibroblasts via changes in FAK phosphorylation through a PKCa-dependent mechanism. NG2 might regulate anoikis signaling in a PKCa-dependent manner by binding to PKCa 17 or modulating its degradation or transcription. Future experimentation will help clarify this situation. Another important area of investigation may include determination of the phosphorylation status of NG2 under control and proapoptotic conditions. Phosphorylation of NG2 at Thr-2256 or Thr-2314 controls its localization to specific membrane microdomains, along with its ability to activate b1 integrins and downstream signaling pathways to selectively stimulate cell motility or proliferation. 17 It seems possible that NG2's phosphorylation state and localization pattern influence its ability to direct integrin-mediated anoikis signaling in response to altered matrix composition.
Materials and Methods
Cell culture. Primary human ligament fibroblasts were obtained as described. 1 Fibroblasts were maintained in a-minimal essential medium containing 10% fetal bovine serum and 1% penicillin-streptomycin-fungizone. NG2-null fibroblasts and wild-type control fibroblasts 26 were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1% penicillin-streptomycin.
Altered FN matrix/recombinant FN proteins. Two recombinant FN proteins, V þ H þ (control) and V þ HÀ (altered matrix), were prepared as described. 32 The V þ HÀ fragment is comparable to the 40 kDa naturally occurring proteolytic fragment found in diseased patient fluids. 33, 34 Both fragments rely on interactions with the heparin-binding domain and V region of FN.
Plasmids and siRNAs. NG2 cDNA (pcDNAamp/NG2) has been described. 25, 35 NG2 siRNA and mutant control NG2 siRNA were transcribed in vitro with chemically synthesized DNA oligonucleotides and T7 RNA polymerase as described. 36 Synthesis and annealing were confirmed by non-denaturing PAGE. Human NG2 was targeted with siRNA (5 0 -GUGGACCAGUACCCUACGG-3 0 ) corresponding to human melanoma-associated CSPG (cspg4). A non-functional mutant control siRNA with four consecutive nucleotide mismatches served as a control (5 0 -GUAGAUCAAUUGGGUACACUU-3 0 ). Only the sense strand is shown in each case. NG2 suppression was also confirmed with commercially available siRNA and cognate Stealth RNAi negative control (Invitrogen, Carlsbad, CA, USA). Integrin a4 cDNA was from the American Type Culture Collection (Manassas, VA, USA). Integrin a4 siRNA was from Ambion (Austin, TX, USA). PKCa cDNA was a gift from Apoptotic cell death detection by ELISA. Histone-associated DNA fragments (mono-and oligonucleosomes) in the cytoplasm were determined by Cell Death Detection ELISA PLUS ELISA kit (Roche Diagnostics, Indianapolis, IN, USA). Briefly, the lysates from floating and adherent cells were placed in a streptavidincoated microplate and incubated with a mixture of anti-histone-biotin and anti-DNA peroxidase. After addition of peroxidase substrate (ABTS), the absorbance was measured at 405 nm.
Analysis of NG2 and integrin a4 by flow cytometry. NG2 and integrin a4 expression were quantified by flow cytometry. After treatment with recombinant FN proteins, cells were washed with PBS and pelleted by centrifugation. Parallel samples were incubated with B5 mouse anti-NG2 antibody (American Type Culture Collection) or rabbit anti-integrin a4 antibody (Santa Cruz Biotechnology) at 4 1C for 2 h. Cells were washed in PBS, pelleted by centrifugation, and incubated with a second FITC-conjugated antibody for 30 min in the dark. Samples were stored in the dark for 20 min before analysis.
Immunofluorescence. Cells were incubated with B5 mouse anti-NG2 and rabbit anti-integrin a4 antibody (Chemicon, Temecula, CA, USA) and prepared for immunofluorescence as described. 2 Western blotting. Samples were electrophoretically resolved by standard SDS-PAGE and western blotting as previously described. 4 Samples for NG2 (proteoglycan) detection were pretreated with 0.2 U of chondroitinase ABC for 1 h at 37 1C. NG2 was detected with B5 monoclonal antibody. Polyclonal anti-integrin a4, a5, CD44, and syndecan-2 were from Santa Cruz Biotechnology. Polyclonal antiintegrin av was from Chemicon. Polyclonal anti syndecan-4 was from Biovision (Mountain View, CA, USA). Densitometric analysis of bands of exposed films was performed using NIH Image software. RNAi. Cells were transiently transfected with siRNA, non-functional control NG2 siRNA, or Stealth RNAi Negative Control (Invitrogen) using Lipofectamine 2000. Cells were then treated with recombinant FN proteins in serum-free medium for experiments. To monitor gene silencing, cell extracts were assessed by western blot 24, 36, and 48 h after transfection.
Real-time RT-PCR. mRNA expression of NG2 and integrin a4 was measured by two-step quantitative RT-PCR. After treatment with FN proteins, total RNA was extracted with the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). First-strand cDNAs were synthesized with an anchored oligo(dT) primer (Invitrogen). Real-time PCR was performed on an Applied Biosystems 7500 Real Time PCR System. Target gene expression was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primers were from Applied Biosystems (Foster City, CA, USA). The sequences were NM_001897.3 (human NG2), NM_000885.4 (human integrin a4), and NM_002046.3 (human GAPDH).
Statistical analysis. Data were analyzed by a two-way ANOVA and the intergroup differences were determined by Fisher's PLSD test. Innergroup differences were analyzed by an unpaired Student's t-test. Po0.05 was considered significant. Values are mean ± S.E.M. All experiments were performed in triplicate. 
